NEULANDLAB

HealthcareDrug Manufacturers - Specialty & GenericLarge Cap
Neuland Laboratories Limited

Neuland Laboratories Limited operates in the Healthcare sector, specializing as a Drug Manufacturer of Specialty & Generic products. The company engages in the manufacture and sale...

हिन्दी में

न्यूलैंड लैबोरेटरीज लिमिटेड हेल्थकेयर सेक्टर में कार्यरत है, जो स्पेशलिटी और जेनेरिक उत्पादों के ड्रग मैन्युफैक्चरर के रूप में विशेषज्ञता रखती है। यह कंपनी भारत, यूरोप, संयुक्त राज...

₹20,890-0.59%1D
Previous trading day close · Data updates after market close
1W: -4.5%
1M: -9.9%
6M: +43.9%
1Y: +32.0%
64/100
AverageResearch Score
Market Cap
₹23.1K Cr
Large Cap
P/E Ratio
66.77
Premium
P/B Ratio
15.94
Premium
ROE
18.5%
Strong
ROCE
29.9%
Excellent
Debt / Equity
0.10
Low debt
Div. Yield
0.2%
EV/EBITDA
39.85
Expensive
52W Low: ₹11,500Current: ₹20,89052W High: ₹24,225
At 74% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
78/100
Growth
Revenue, EPS, profit growth
83/100
Valuation
PE, PB, EV/EBITDA vs sector
15/100
Risk
Debt levels, volatility, coverage
81/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
66.77(Premium)
Forward P/E
56.84(Premium)
P/B Ratio
15.94(Premium)
P/S Ratio
11.84(Expensive)
EV/EBITDA
39.85(Expensive)
Dividend Yield
0.2%
5Y CAGR
53.8%(High growth)
Revenue Growth
30.5%(High)
Profitability
ROE
18.5%(Good)
ROCE
29.9%(Excellent)
ROA
13.0%(Efficient)
Net Margin
17.7%(High)
EBITDA Margin
29.5%
Financial Health
Debt to Equity
0.10(Low debt)
Current Ratio
2.45(Healthy)
Quick Ratio
1.62(Good)
Interest Coverage
21.42x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
18(Oversold)
RSI Exp (14)
26(Oversold)
MACD
-337.951(Bearish)
MACD Signal
-189.665
BB Position
11%(Lower band)
BB Width
14.26%(Normal)
ADX (14)
54.3(Very Strong)
Williams %R
-92.5(Oversold)
MFI (14)
31(Neutral)
CCI (20)
-119(Oversold)
Stoch %K
7(Oversold)
ATR (14)
692.86(Avg True Range)
OBV (M)
3.8(Positive)
1W OBV Chg
0.8%(Increasing)
Rel Volume
0.40x(Low activity)
Volatility
48.5%(High)
Max DD 1Y
-41.2%(High loss)
EMA 200
18380.9
EMA 50
21668.1
SMA 200
17094.0
vs SMA 50
-6.4%(Below SMA50)
vs SMA 200
22.2%(Above SMA200)
Volume
24.6K
Avg Vol 3M
0.6L
Shareholding Pattern
Promoter
32.6%
Low stake
FII
20.5%
Strong foreign interest
DII / MF
15.8%
Strong MF interest
Share NEULANDLAB
Share this stock analysis with your network
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.